Skip to main content
Equibles
XGN logo

XGN · Exagen Inc. · Metrics

Track XGN — free

Use XGN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$7.31 +0.01 (+0.14%)
Rebalance outlook locked
Market Cap
$183.63M
Shares
24.23M

XGN metrics

74 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$7.30
Market cap
$183.63M

Price action

20 metrics
Price change (1W)
+2.6%
Price change (30D)
+14.2%
Price change (3M)
+76.7%
Price change (6M)
+130.4%
Price change (YTD)
+24.7%
Price change (1Y)
-22.9%
Trailing year
Price change (5Y)
-44.7%
52-week high
$11.96
52-week low
$2.65
Change from 52-week high
-36.6%
Change from 52-week low
+186.0%
Annualized volatility
82.4%
Annualized volatility (3M)
101.1%
Beta
2.3
RSI (14D)
65.2
Price vs SMA 50
+31.0%
Price vs SMA 200
+58.6%
Avg volume (3M)
307,980
Relative volume
0.5
Average dollar volume
$1.79M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
24.23M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.6×
reciprocal yield 39.1%
EV / EBITDA
—
EV / EBIT
—
P / sales
2.6×
reciprocal yield 38.7%
P / book
15.0
reciprocal yield 6.7%
FCF yield
-4.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-10.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.4×
reciprocal yield 73.8%
EV / revenue historical average (5Y)
1.3×
reciprocal yield 78.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
58.6%
Operating margin
-18.6%
Trailing 12 months
Net margin
-26.6%
Gross profit (TTM)
$41.70M
Operating profit (TTM)
−$13.21M
Net income (TTM)
−$18.92M
Trailing 12 months
Diluted EPS (TTM)
$-0.82
FCF margin
-10.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-1,777.10

Growth

11 metrics
Revenue growth YoY
+15.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$71.12M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+14.6%
Year over year · more shares
Revenue CAGR (3Y)
+13.5%
Revenue CAGR (5Y)
+9.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-154.9%
Return on assets
-36.4%
Debt / equity
1.9
Current ratio
3.2
EBITDA (TTM)
−$10.81M
Free cash flow (TTM)
−$7.59M
Quick ratio
3.2
Interest coverage
-2.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$1.75M
Latest balance sheet
Cash & equivalents
$24.59M
Total assets
$51.94M
Total debt
$22.84M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$6.50M
Capital expenditures (TTM)
$1.09M
R&D (TTM)
$6.47M
SG&A (TTM)
$48.45M
Stock compensation (TTM)
$2.93M
R&D / revenue
9.1%
Stock compensation / revenue
4.1%

Ownership (13F)

3 metrics
13F filers
57
13F filer change QoQ
-4
Institutional ownership
32.8%

Short interest

3 metrics
Short interest
3.9%
Latest settlement · 1.5 days to cover
Days to cover
1.5d
Short-squeeze score
49 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$148,782
Insider-sentiment score
41 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1274737 CUSIP 30068X103 13F (30d) 46 filings 46 filers Visit website Investor relations